Dow Jones U.S. Pharmaceuticals Index

D.J. US Pharmaceutical Top 10: Value Investment Strategy

TOP 10 Value	VALUEVVV		GROWTHVV		SAFETYVV		COMBINED
1. Prestige (L, US)  Pharmaceuticals
1. Prestige (L, US)   Pharmaceuticals	79		60		30		80
2. Pfizer (XXL, US)  Pharmaceuticals
2. Pfizer (XXL, US)   Pharmaceuticals	75		30		22		27
3. Phibro Animal (L, US)  Pharmaceuticals
3. Phibro Animal (L, US)   Pharmaceuticals	67		22		32		29
4. Lannett (M, US)  Pharmaceuticals
4. Lannett (M, US)   Pharmaceuticals	51		60		36		70
5. Catalent (L, US)  Pharmaceuticals
5. Catalent (L, US)   Pharmaceuticals	41		83		45		100

June 8, 2018. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)

D.J. US Pharmaceutical Top 10: Growth Investment Strategy

TOP 10 Growth	VALUEVVV		GROWTHVV		SAFETYVV		COMBINED
1. Supernus Pharma (M, US)   Pharmaceuticals
1. Supernus Pharma (M, US)   Pharmaceuticals	7		100		82		100
2. Nektar (L, US)   Pharmaceuticals
2. Nektar (L, US)   Pharmaceuticals	1		100		12		22
3. AbbVie (XXL, US)   Biotechnology
3. AbbVie (XXL, US)   Biotechnology	26		97		5		27
4. Catalent (L, US)   Pharmaceuticals
4. Catalent (L, US)   Pharmaceuticals	41		83		45		100
5. Eli Lilly (XXL, US)   Pharmaceuticals
5. Eli Lilly (XXL, US)   Pharmaceuticals	19		61		33		22
6. Zoetis (XL, US)   Pharmaceuticals
6. Zoetis (XL, US)   Pharmaceuticals	21		61		26		20
7. Prestige (L, US)   Pharmaceuticals
7. Prestige (L, US)   Pharmaceuticals	79		60		30		80

June 8, 2018. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)

D.J. US Pharmaceutical Top 10: Safety Investment Strategy

TOP 10 Safety	VALUEVVV		GROWTHVV		SAFETYVV		COMBINED
1. Supernus Pharma (M, US)   Pharmaceuticals
1. Supernus Pharma (M, US)   Pharmaceuticals	7		100		82		100
2. Pacira BioSciences (M, US)   Pharmaceuticals
2. Pacira BioSciences (M, US)   Pharmaceuticals	5		33		50		33
3. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
3. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals	10		40		49		16
4. Catalent (L, US)   Pharmaceuticals
4. Catalent (L, US)   Pharmaceuticals	41		83		45		100
5. Johnson & Johnson (XXL, US)   Pharmaceuticals
5. Johnson & Johnson (XXL, US)   Pharmaceuticals	17		40		38		16

June 8, 2018. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)

D.J. US Pharmaceutical Top 10: Combined Investment Strategy

TOP 10 Combined	VALUEVVV		GROWTHVV		SAFETYVV		COMBINED
1. Supernus Pharma (M, US)   Pharmaceuticals
1. Supernus Pharma (M, US)   Pharmaceuticals	7		100		82		100
2. Catalent (L, US)   Pharmaceuticals
2. Catalent (L, US)   Pharmaceuticals	41		83		45		100
3. Prestige (L, US)   Pharmaceuticals
3. Prestige (L, US)   Pharmaceuticals	79		60		30		80
4. Lannett (M, US)   Pharmaceuticals
4. Lannett (M, US)   Pharmaceuticals	51		60		36		70
5. Pacira BioSciences (M, US)   Pharmaceuticals
5. Pacira BioSciences (M, US)   Pharmaceuticals	5		33		50		33

June 8, 2018. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)

☀ This company has a special achievement which is documented on its stock research page.

Top 10 lists may contain fewer than 10 stocks due to Obermatt’s top 10 quality standards.

Top 10 Stocks from the purely finance fact-based Obermatt Method for the investment strategies Value, Growth and Safety in the stock index Dow Jones U.S. Pharmaceuticals Index from June 8, 2018.